Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Critical Outcome Technologies Inc V.COT

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  COTQF

Critical Outcome Technologies Inc is a biotechnology company. The Company is engaged in applying its proprietary computer-based technology, CHEMSAS, to identify and optimize drug candidates at early stage of preclinical drug development.
Price: $0.30 | Change: +$0.005 | %Change: +1.69%
Volume: 40,000 | Day High/Low: 0.335/0.29 | 52 Week High/Low: 0.38/0.12


View modes: 
0 stars

Key commercialization initiatives advanced during fiscal2014

Critical Outcome Technologies Reports Year-End Financial and Operating Results Key commercialization initiatives advanced during fiscal 2014 Thursday, July 24, 2014   Critical Outcome...read more
0 stars

some news

http://www.stockhouse.com/news/press-releases/2014/07/16/critical-outcome-technologies-inc-announces-warrant-term-amendment  rate and reply
0 stars

no news

nothing, zip, nada, not even a hint of what may or may not have happened in san diago.  rate and reply
0 stars

cibc attempting to sell also

about 810,000 shares from .32  to .35 cents.  does anyone know why?  is there news to come soon?  rate and reply
0 stars

almost 300,00 shares exchanged today

with BMO selling  or attempting to sell over 125,000 shares, anyone know why?  price dropped .4 cents to .24  rate and reply
0 stars

san diego

I wonder what;s going on there?  rate and reply
0 stars

RE:Personalized Cancer Care With Project ROSALIND

yep and  I like this statement : " and are talking with a number of potential partners about commercial validation opportunities," added Dr. Danter.  rate and reply
0 stars

Personalized Cancer Care With Project ROSALIND

Critical Outcome Technologies Seeks to Redefine Personalized Cancer Care With Project ROSALIND ROSALIND, a patent-pending cancer cell simulation, will be introduced at the upcoming BIO International...read more
1 star

RE:NEWS!! COT Receives Orphan Drug Designation For COTI-2

So we jumped 50% just ahead of the news? Either someone had high hopes or someone has a big mouth lol. Very interesting story though. * Always conduct your own due diligence when investing and...read more
0 stars

NEWS!! COT Receives Orphan Drug Designation For COTI-2

Critical Outcome Technologies Receives Orphan Drug Designation For COTI-2 Designation for treatment of ovarian cancer provides further support for the clinical development of COTI-2 Tuesday, June...read more
0 stars

RE:RE:great volume today

wow, just hit 29 , days after the big volume days cleaning up supply around 19-23 cents...   if we can close over 28 this week that will be over the Feb highs and indicate a new leg higher possibly...read more
0 stars

Trading in U.S. on OTCQB Under Symbol COTQF

Critical Outcome Technologies to Commence Trading in U.S. on OTCQB Under Symbol COTQF Enhancing investor access and awareness in the U.S. market Monday, June 16, 2014   Critical Outcome...read more
0 stars

research report target 62 cents

Critical Outcome Technologies Inc.: SeeThruEquity Initiates Research Coverage Friday, June 13, 2014   Critical Outcome Technologies Inc.: SeeThruEquity Initiates Research Coverage 19:42 EDT...read more
0 stars

RE:great volume today

Nice to see some strong buying... a million or so at ,195 and now buying all on offer at ,215 it looks like.   Good sign of interest.  rate and reply
0 stars

Present at 16th International p53 Workshop in Sweden

Critical Outcome Technologies Invited to Present at 16th International p53 Workshop in Sweden Friday, June 13, 2014   Critical Outcome Technologies Invited to Present at 16th International p53...read more
0 stars

great volume today

500K at .195, someone buying in bulk finally............... with good news these things can really take off, but lots of patience needed to find the right one.  The other one I really like is IMV...read more
0 stars

it's a good thing?

http://www.stockhouse.com/news/press-releases/2014/05/27/critical-outcome-technologies-selected-to-present-at-multiple-investor  rate and reply
0 stars

RE:Financing Increases Runway to the Clinic for COTI-2

As I understand we are expecting here a licensing deal?   I hope in the same scale :   http://www.stockhouse.com/news/press-releases/2014/04/24/celgene-acquires-late-stage-product-for-crohn-s...read more
0 stars

Financing Increases Runway to the Clinic for COTI-2

Financing Increases Runway to the Clinic for COTI-2, Critical Outcome's Lead Cancer Drug Candidate Thursday, May 01, 2014   Financing Increases Runway to the Clinic for COTI-2, Critical Outcome...read more
0 stars

Applies for Orphan Drug Designation

Critical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian Cancer Orphan Drug Designation Could Serve Unmet Medical Need and Provide Significant Financial...read more